CPB Nonspecified Subtype Regulates Protein Homeostasis (P11267)

Target Name: Carboxypeptidase B

NCBI ID: P11267

Carboxypeptidase B

Other Name(s): None

CPB Nonspecified Subtype Regulates Protein Homeostasis

Carboxypeptidase B (CPB) is an enzyme that is involved in the breakdown of peptides, which are large chains of amino acids that are derived from proteins. This enzyme is a critical player in the regulation of protein homeostasis, as it helps to remove damaged or unnecessary proteins from the body. There are several different subtypes of CPB, each with a distinct function.

One of the subtypes of CPB that is of particular interest is the nonspecified subtype. This subtype of CPB is characterized by the presence of a specific active site on the enzyme's catalytic residue, which is responsible for the binding of substrate peptides. This site has been shown to be important for the efficient binding and cleavage of substrate peptides, and is the site of the enzyme's active catalytic activity.

The nonspecified subtype of CPB has been shown to play a critical role in the regulation of protein homeostasis. In particular, it is involved in the degradation of damaged or unnecessary proteins, which is important for maintaining the structural and functional integrity of tissues. Studies have shown that the nonspecified subtype of CPB is involved in the clearance of a wide variety of substrates, including damaged proteins, misfolded proteins, and proteins that have been modified in ways that alter their stability or function.

In addition to its role in protein homeostasis, the nonspecified subtype of CPB has also been shown to be involved in the regulation of cellular processes. For example, it has been shown to be involved in the regulation of cell division, and in the control of cell growth and differentiation. In addition, the nonspecified subtype of CPB has been shown to play a role in the regulation of inflammation and immune response.

Given the critical role that the nonspecified subtype of CPB plays in the regulation of protein homeostasis, it is a promising target for drug development. Researchers have been actively searching for small molecules that can inhibit the activity of this enzyme, with the goal of developing treatments for a variety of diseases. In addition, the study of the nonspecified subtype of CPB has also provided new insights into the regulation of protein homeostasis, and has broadened our understanding of the complex mechanisms that govern protein function.

Overall, the nonspecified subtype of CPB is an important enzyme that is involved in the regulation of protein homeostasis. Its role in this process is critical for the maintenance of cellular and tissue health, and its regulation by small molecules has the potential to lead to new treatments for a variety of diseases. Further research is needed to fully understand the mechanisms of its regulation, and to develop effective treatments based on this understanding.

Protein Name: Carboxypeptidase B (nonspecified Subtype)

The "Carboxypeptidase B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Carboxypeptidase B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets